Óêðàèíñêèé ïóëüìîíîëîãè÷åñêèé æóðíàë |
||||||||||||
Îá èíñòèòóòå: ëå÷åáíî-äèàãíîñòè÷åñêàÿ ðàáîòà, Íîâîñòè: Íàøè èçäàíèÿ: "Óêðàèíñêèé
ïóëüìîíîëîãè÷åñêèé æóðíàë" (ÓÏÆ), Îðèãèíàëüíûå ñòàòüè: îðèãèíàëüíûå íàó÷íûå ñòàòüè, ðàíåå íèãäå íå ïóáëèêîâàâøèåñÿ Íîâîââåäåíèÿ:
ìåòîäè÷åñêèå ðåêîìåíäàöèè,
èíôîðìàöèîííûå ïèñüìà, Ïàòåíòû: ïàòåíòû è àâòîðñêèå ñâèäåòåëüñòâà èíñòèòóòà Îò÷åòû î ÍÈÐ: ðåôåðàòû çàêîí÷åííûõ íàó÷íî-èññëåäîâàòåëüñêèõ ðàáîò Ïîäãîòîâêà êàäðîâ:
êëèíè÷åñêàÿ îðäèíàòóðà, â ïîìîùü àñïèðàíòó è ñîèñêàòåëþ Íàó÷íûå ôîðóìû: ðåçîëþöèè è îáðàùåíèÿ ñúåçäîâ, êîíôåðåíöèé, ñîâåùàíèé... Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâ: Èíôîðìàöèÿ äëÿ íàñåëåíèÿ: ïîëåçíàÿ
èíôîðìàöèÿ î çàáîëåâàíèÿõ ëåãêèõ, èõ ïðîôèëàêòèêå è ëå÷åíèè |
2011. - ¹
2.
|
Ë. À. ßøèíà
ÁÀÇÈÑÍÀß ÒÅÐÀÏÈß ÁÎËÜÍÛÕ ÕÎÇË
®
L. A. Yashina
MAINTENANCE THERAPY OF PATIENTS WITH COPD
À. ß. Äçþáëèê
ÎÁÎÑÒÐÅÍÈÅ ÕÎÇË: ÑÎÂÐÅÌÅÍÍÛÅ ÏÐÈÍÖÈÏÛ ËÅ×ÅÍÈß
®
A. Ya. Dziublyk
EXACERBATION OF COPD: MODERN MANAGEMENT PRINCIPLES
Â. Ê. Ãàâðèñþê
ÏÐÈÍÖÈÏÛ ÒÅÐÀÏÈÈ ÁÎËÜÍÛÕ Ñ ÎÑËÎÆÍÅÍÈßÌÈ ÕÎÇË
®
V. K. Gavrysiuk
PRINCIPLES OF MANAGEMENT OF PATIENTS WITH COPD COMPLICATIONS
®
T. A. Pertseva
UPLIFT® STUDY RESULTS: SUB-ANALYSIS IN SUBGROUP OF PREVIOUSLY UNTREATED
PATIENTS
Ë. À. ßøèíà
ÐÅÇÓËÜÒÀÒÛ ÈÑÑËÅÄÎÂÀÍÈß POET È ÈÕ ÊËÈÍÈ×ÅÑÊÎÅ ÇÍÀ×ÅÍÈÅ Â ÏÐÀÊÒÈÊÅ ÂÐÀ×À
®
L. A. Yashina
POET STUDY RESULTS AND ITS CLINICAL SIGNIFICANCE IN MEDICAL PRACTICE
Ì. Ì. Îñòðîâñüêèé
ÁÐÎÍÕÎÎÁÑÒÐÓÊÒÈÂÍÈÉ ÑÈÍÄÐÎÌ: ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß Ä²ÀÃÍÎÑÒÈÊÈ ÒÀ ˲ÊÓÂÀÍÍß
®
M. M. Ostrovskyi
BRONCHIAL OBSTRUCTIVE SYNDROME: DIAGNOSIS AND MANAGEMENT
Ì. À. Ïîëÿíñêàÿ
ÎÖÅÍÊÀ ÝÔÔÅÊÒÈÂÍÎÑÒÈ ÍÅÁÓËÀÉÇÅÐÍÎÉ ÒÅÐÀÏÈÈ ÁÅÐÎÄÓÀËÎÌ
®
M. A.
Polianska
EVALUATION OF EFFECTIVENESS OF NEBULIZER THERAPY USING BERODUAL
®
T. A. Pertseva, E. V. Mironchenko
CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE ROLE OF ANTI-INFLAMMATORY THERAPY
®
Yu. M. Mostovoy, A. V. Demchuk
THE CHOICE OF ANTIBIOTIC MEDICATION IN EXACERBATION OF COPD IN OUT-PATIENT
SETTING BASED ON PHARMACOECONOMIC ANALYSIS
®
L. I.
Konopkina, T. A. Pertseva
NOVEL ASPECTS IN TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY
DISEASE
Ò. À. Ïåðöåâà
ÝÏÈÄÅÌÈÎËÎÃÈß È ÄÈÀÃÍÎÑÒÈÊÀ ÕÐÎÍÈ×ÅÑÊÎÃÎ ÎÁÑÒÐÓÊÒÈÂÍÎÃÎ ÇÀÁÎËÅÂÀÍÈß ËÅÃÊÈÕ
®
T. A. Pertseva
EPIDEMIOLOGY AND DIAGNOSING OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Ë. À. ßøèíà
ÎÁÎÑÍÎÂÀÍÈÅ ÖÅËÅÑÎÎÁÐÀÇÍÎÑÒÈ È ÀÍÀËÈÇ ÝÔÔÅÊÒÈÂÍÎÑÒÈ ÊÎÌÁÈÍÈÐÎÂÀÍÍÎÉ ÒÅÐÀÏÈÈ
ÕÎÇË
®
L. A. Yashina
JUSTIFICATION OF USE AND EVALUATION OF EFFICACY OF COMBINATION THERAPY IN
COPD
Þ. Ì. Ìîñòîâîé, À. Â. Äåì÷óê
ÕÎÇË. ÑÈÑÒÅÌÍÛÅ ÝÔÔÅÊÒÛ È ÈÕ ÏÐÎÔÈËÀÊÒÈÊÀ
®
Yu. M. Mostovoy, A. V. Demchuk
COPD: SYSTEMIC EFFECTS AND THEIR PROPHYLAXIS
Ë. À. ßøèíà
ÊÎÍÒÐÎËÜ ÍÀÄ ÂÎÑÏÀËÈÒÅËÜÍÛÌ ÏÐÎÖÅÑÑÎÌ ÏÐÈ ÕÎÇË
®
L. A. Yashina
INFLAMMATION CONTROL IN COPD
À. ß. Äçþáëèê
ÍÎÂÛÅ ÂÎÇÌÎÆÍÎÑÒÈ Â ÒÅÐÀÏÈÈ ÁÎËÜÍÛÕ ÕÎÇË
®
A. Ya. Dziublyk
NEW OPPORTUNITIES IN MANAGEMENT OF COPD PATIENTS
Ò. À. Ïåðöåâà
ÏÐÎÒÈÂÎÂÎÑÏÀËÈÒÅËÜÍÀß ÒÅÐÀÏÈß ÁÎËÜÍÛÕ ÕÎÇË: ÐÅÇÓËÜÒÀÒÛ ÊËÈÍÈ×ÅÑÊÈÕ
ÈÑÑËÅÄÎÂÀÍÈÉ
®
T. A.
Pertseva
ANTI-INFLAMMATORY THERAPY IN COPD PATIENTS: CLINICAL TRIAL RESULTS
Ñ. Ñ. Ñèìîíîâ
ÀÍÒÈÁÈÎÒÈÊÎÒÅÐÀÏÈß ÈÍÔÅÊÖÈÎÍÍÛÕ ÎÁÎÑÒÐÅÍÈÉ ÕÐÎÍÈ×ÅÑÊÎÃÎ ÁÐÎÍÕÈÒÀ
®
S. S. Simonov
ANTIBIOTIC THERAPY OF INFECTIOUS EXACERBATIONS OF CHRONIC BRONCHITIS
®
N. E. Monogarova, T. V. Zakomoldina, A. S. Panchishko, E. E.
Monogarova, A. V. Semendiayeva
THERAPY OF COPD PATIENTS: IS IT POSSIBLE TO INFLUENCE A PROGNOSIS?
Ò. À. Ïåðöåâà, Â. Â. Äìèòðè÷åíêî
ÌÀÊÐÎËÈÄÛ: ÀÍÒÈÁÀÊÒÅÐÈÀËÜÍÛÅ ÝÔÔÅÊÒÛ È ÍÅ ÒÎËÜÊÎ
®
T. A. Pertseva, V. V. Dmitrichenko
MACROLIDES: ANTIBACTERIAL AND NON-ANTIBACTERIAL EFFECTS
Ñ. È. Ëåùåíêî
ÍÅÁÓËÀÉÇÅÐÍÀß ÒÅÐÀÏÈß — ÑÎÂÐÅÌÅÍÍÛÉ ÌÅÒÎÄ ËÅ×ÅÍÈß ÁÎËÜÍÛÕ ÕÎÇË
®
S. I. Leshchenko
NEBULIZER THERAPY — MODERN METHOD OF TREATMENT OF COPD PATIENTS
Ñ. Ñ. Ñèìîíîâ
ÀÍÒÈÁÈÎÒÈÊÎÒÅÐÀÏÈß ÈÍÔÅÊÖÈÉ ÍÈÆÍÈÕ ÄÛÕÀÒÅËÜÍÛÕ ÏÓÒÅÉ: Â ÔÎÊÓÑÅ ÌÀÊÐÎËÈÄÛ
®
S.S. Simonov
ANTIBIOTIC THERAPY OF LOWER RESPIRATORY TRACT INFECTIONS: A FOCUS ON
MACROLIDES
ÎÐÈòÍÀËÜͲ ÑÒÀÒÒ² / ÎRIGINALS
®
®
®
A. V. Lytvynenko, V. V. Kuts
CENTRAL INSPIRATORY ACTIVITY IN PATIENTS WITH HYPOCAPNIA
®
®
ÎÃËßÄÈ Ë²ÒÅÐÀÒÓÐÈ / REVIEWS
®
U. B. Chulovska, O. S. Tolokh
CORRECT DECISIONS IN APPLICATION OF ANTIBACTERIAL THERAPY OF CHRONIC
OBSTRUCTIVE PULMONARY DISEASE EXACERBATION
²ÍÔÎÐÌÀÖ²ß / INFORMATION
®
EFFICACY OF MONTELUKAST IN PATIENTS WITH ASTHMA AND CONCOMITANT DISEASES OF NASAL CAVITY AND PARANASAL SINUSES
ÏÐÎÔÅÑÎÐÓ ÎËÅÊÑÀÍÄÐÓ ßÐÎÑËÀÂÎÂÈ×Ó ÄÇÞÁËÈÊÓ — 60 ÐÎʲÂ
®
PROFESSOR’S ALEXANDR DZIUBLYK 60TH ANNIVERSARY
ÑÎËÄÀÒ×ÅÍÊÎ ÑÅÐÃÅÉ ÑÅÐÃÅÅÂÈ× (Ê 60-ËÅÒÈÞ ÑÎ ÄÍß ÐÎÆÄÅÍÈß)
®
PROFESSOR’S SERGEY SOLDATCHENKO 60TH ANNIVERSARY
ÑÒÀÍÄÀÐÒÈ Ä²ÀÃÍÎÑÒÈÊÈ ÒÀ ˲ÊÓÂÀÍÍß / STANDARDS OF DIAGNOSTICS AND TREATMENT
®
AN OFFICIAL ATS/ERS/JRS/ALAT STATEMENT: IDIOPATHIC PULMONARY FIBROSIS: EVIDENCE-BASED GUIDELINES FOR DIAGNOSIS AND MANAGEMENT
Home •
Ïîèñê •
Ïðî èíñòèòóò • Íîâîñòè •
Íàøè èçäàíèÿ •
Îðèãèíàëüíûå ñòàòòüè •
Íîâîââåäåíèÿ
Ïàòåíòû •
Îò÷åòû î ÍÄÐ •
Ïîäãîòîâêà êàäðîâ • Íàó÷íûå
ôîðóìû
Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâ •
Èíôîðìàöèÿ äëÿ íàñåëåíèÿ •
Ìåäèöèíñêèå óñëóãè